Biorad Medisys Accelerates Vascular and Stroke Care Through New Partnerships and Technology

Biorad Medisys Accelerates Vascular and Stroke Care Through New Partnerships and Technology

Investment in Belgium’s Frid Mind Technologies to Advance Stroke Prevention
Acquisition of Stake in Israel’s Motion Informatics to Strengthen Stroke Rehabilitation Portfolio  
Development of advanced Braided Devices for Neurovascular and Peripheral Vascular Care 

Pune, India – October 15, 2025 – Biorad Medisys Pvt. Ltd. today outlined a series of product development initiatives and investments in the neurovascular and peripheral vascular markets. 
Biorad has invested in Frid Mind Technologies (FMT), a Belgium-based company founded by Noureddine Frid. FMT has developed a [patented stroke-prevention product using advanced braiding technology]. The technology has completed preclinical trials and two first-in-human cases with positive long-term follow-up. 
In addition, Biorad has acquired 10 % stake in Motion Informatics Ltd. (formerly Stroke Rehab Ltd.), an Israel-based company specializing in stroke rehabilitation solutions. Motion Informatics manufactures and markets the US FDA-approved Stimel-03 device, which integrates NMES, FES, and Biofeedback technologies to support patient rehabilitation. Biorad also holds manufacturing and distribution rights for the device in select geographies, including India and the United States. 
Commenting on these initiatives, Mr. J. M. Hegde, Managing Director, Biorad Medisys, said: 

“Our collaborations with [FMT] and Motion Informatics, together with our work in advanced braiding technologies, reflect our ongoing efforts in the field of vascular and stroke care.”